These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27093803)

  • 1. [The Destruction of Pharmaceutical Products as an Element of the Efficiency of State Control (Supervision) Over the Circulation of Medicines].
    Bidarova FN
    Vestn Ross Akad Med Nauk; 2015; (6):741-7. PubMed ID: 27093803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The actual Russian legislation in sphere of turn-over of drug agents and psychotropic substances].
    Abramov AY; Kosolapova NV; Mikhaiylova YV
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2014; (2):9-14. PubMed ID: 24960990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substandard drugs: a potential crisis for public health.
    Johnston A; Holt DW
    Br J Clin Pharmacol; 2014 Aug; 78(2):218-43. PubMed ID: 24286459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Furthering benefit/risk ratio and cost effectiveness of anticancer drugs.
    Golikov AS; Tikhomirova AV
    Int J Risk Saf Med; 2015; 27 Suppl 1():S49-50. PubMed ID: 26639707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Medicines in Portugal: A Retrospective Review of Medicine Recalls (2000-2015).
    Machado Reis AT; Berardo BFR; Loureiro R
    PDA J Pharm Sci Technol; 2018; 72(1):44-49. PubMed ID: 29030530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies.
    Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G
    Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current malaria situation in the Republic of Kazakhstan].
    Bismil'din FB; Shapieva ZhZh; Anpilova EN
    Med Parazitol (Mosk); 2001; (1):24-33. PubMed ID: 11548308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Entry Lag of Innovative Drugs in Russia, 2010-2019.
    Chaplenko A; Gildeeva G; Vlassov V
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34064608
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug quality control work in Daru: observations during 1983-1986.
    Kibwage IO; Ogeto JO; Maitai CK; Rutere G; Thuranira J; Ochieng' A
    East Afr Med J; 1992 Oct; 69(10):577-80. PubMed ID: 1473513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
    Juhlin K; Karimi G; Andér M; Camilli S; Dheda M; Har TS; Isahak R; Lee SJ; Vaughan S; Caduff P; Norén GN
    Drug Saf; 2015 Apr; 38(4):373-82. PubMed ID: 25687792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The radiation environment in the Russian Federation according to the results of radiohygienic certification].
    Onishchenko GG
    Gig Sanit; 2009; (3):4-7. PubMed ID: 19645102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration of quality, safety and efficacy of biological products subject to changes in their manufacturing process].
    Vasil'ev AN; Gavrishina EV; Niiazov RR; Snegireva AA; Adonin VK
    Antibiot Khimioter; 2013; 58(9-10):45-55. PubMed ID: 24738243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Western quality improvement methods transform the Russian health care system?
    Tillinghast SJ
    Jt Comm J Qual Improv; 1998 May; 24(5):280-98. PubMed ID: 9626620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to adapt to the requirements of "clinical value-oriented drug innovation" for pharmaceutical research in application process of new traditional Chinese medicine].
    Jin F
    Zhongguo Zhong Yao Za Zhi; 2017 May; 42(9):1797-1802. PubMed ID: 29082710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [40th anniversary of the 736th Main Center of State Sanitary and Epidemiological Surveillance of the Russian Defense Ministry].
    Soloveĭ ÈP; Berskiĭ OV; Ian'shin LA
    Voen Med Zh; 2012 Nov; 333(11):86-90. PubMed ID: 23301297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.